Zepbound (tirzepatide) stands as a leading prescription injectable medication for chronic weight management in adults with obesity or overweight who have at least one weight-related condition. Eli Lilly manufactures Zepbound, which received FDA approval in November 2023. As of February 2026, Zepbound remains the most prescribed weight management medication in the United States, with recent […]